According to a new report AI in Medical Imaging Market Size, Share, Competitive Landscape and Trend Analysis Report, by Modality (CT Scan, MRI, X-rays, Ultrasound Imaging, Molecular Imaging), by Technology (Deep Learning, Natural Language Processing (NLP), Computer Vision, Others), by Application (Breast Imaging, Respiratory and Pulmonary, Neurology, Orthopedics, Others), by Industry Vertical (Hospital and Healthcare Providers, Patients, Pharmaceuticals and Biotechnology Companies, Healthcare Payers, Others): Global Opportunity Analysis and Industry Forecast, 2022 – 2032, The global AI in medical imaging market was valued at USD 1.9 billion in 2022 and is projected to reach USD 29.8 billion by 2032, growing at a CAGR of 32.1% from 2023 to 2032.
The AI-in-Medical-Imaging market refers to the application of artificial intelligence (AI) technologies-such as deep learning, machine learning, and natural language processing-to automate, enhance, and accelerate the interpretation and processing of medical images from modalities like CT, MRI, X-ray, and ultrasound. These AI systems help clinicians detect abnormalities, quantify disease progression, support diagnostic decision-making, and improve workflow efficiencies at scale. Demand for such solutions is rising as healthcare systems worldwide face increasing imaging volumes, a shortage of radiologists, and pressures to deliver faster, more accurate clinical outcomes.
Market estimates indicate rapid growth from current valuations in the low billions USD toward significantly larger figures by the early 2030s, driven by technological advances, regulatory clearances, and expanding clinical adoption across specialties like oncology, cardiology, and neurology.
The convergence of powerful computing infrastructure, cloud platforms, and interoperable imaging archives (PACS and RIS) further underpins this expansion, enabling AI solutions to integrate seamlessly into routine diagnostics and hospital workflows.
Download Free PDF Brochure: https://www.alliedmarketresearch.com/request-sample/A12693
Market Dynamics
1. Adoption Drivers
Rising prevalence of chronic diseases (e.g., cancer, cardiovascular and neurological disorders) is fueling demand for early and accurate diagnostics, pushing healthcare providers to deploy AI-enabled imaging solutions that can detect subtle abnormalities and reduce diagnostic turnaround times.
Additionally, the global shortage of trained radiologists has positioned AI as a critical tool to handle increasing imaging volumes, particularly in high-throughput clinical settings.
2. Technology Advancements
Deep learning-particularly convolutional neural networks (CNNs)-has emerged as the dominant technology, thanks to its superior performance in image recognition and segmentation tasks across complex imaging datasets.
Explainable AI (XAI) and hybrid AI solutions are also gaining traction, addressing clinician demand for transparent, interpretable decision support.
3. Workflow & Integration Benefits
AI integration with existing clinical systems like PACS, cloud archives, and radiology information systems is simplifying deployment and enhancing clinical efficiency. Interoperable platforms now allow multiple AI algorithms to operate within a single workflow, reducing barriers to adoption and consolidating vendor solutions.
4. Regulatory and Reimbursement Environment
Regulatory approvals from agencies like the U.S. FDA and CE markings in Europe are accelerating market entry for AI algorithms and imaging platforms. Supportive pathways and reimbursement incentives are reducing adoption hesitancy among providers.
5. Challenges and Barriers
Despite rapid growth, issues such as data privacy, integration complexities, clinician trust gaps, and variable reimbursement frameworks across geographies continue to pose adoption challenges. In some emerging regions, limited infrastructure and funding constraints slow the pace of AI deployment.
Buy Now & Get Exclusive Discount on this Report (330 Pages PDF with Insights, Charts, Tables, and Figures) at: https://www.alliedmarketresearch.com/purchase-enquiry/A12693
Segment Overview
The market is segmented by offering (software platforms, services), technology (deep learning, machine learning, NLP), modality (CT, MRI, X-ray, ultrasound, PET/SPECT), functionality (image analysis, acquisition/reconstruction, workflow automation), and end user (hospitals, diagnostic centers, clinics). Software platforms dominate revenue share due to ease of integration and scalability, while services are among the fastest-growing segments as providers demand implementation and support services. CT imaging holds a strong share by modality, with ultrasound and MRI also expanding rapidly due to real-time and high-resolution diagnostic needs.
In terms of application-based segmentation, the AI in medical imaging market was led by the breast imaging segment in 2022. However, the orthopedics segment is projected to register a higher growth rate during the forecast period. AI applications in breast imaging include advanced algorithms and deep learning models designed to enhance the detection, analysis, and management of breast-related conditions through mammography, MRI, and other imaging modalities. These solutions support radiologists by improving early cancer detection rates, minimizing false positives, and optimizing diagnostic workflows.
Based on industry vertical, hospitals and healthcare providers accounted for the largest market share in 2022. Nevertheless, the patients segment is expected to grow at a faster pace in the coming years. The integration of AI into hospital imaging systems has significantly transformed clinical environments by improving diagnostic accuracy, streamlining radiology workflows, reducing reporting time, and enhancing overall patient outcomes. As patient-centric healthcare models expand, direct patient engagement tools and AI-powered diagnostic accessibility are contributing to rapid growth in the patients segment.
Regional Analysis
Regionally, North America dominated the market in 2022, while Asia-Pacific is anticipated to witness the fastest growth during the forecast period. The North American market is driven by strong adoption of deep learning and machine learning technologies, advanced healthcare infrastructure, supportive regulatory frameworks, strategic collaborations, and access to extensive medical datasets. Meanwhile, Asia-Pacific is benefiting from increasing healthcare digitization, rising investments in AI-based diagnostics, expanding medical infrastructure, and growing awareness of advanced imaging technologies, positioning the region for accelerated expansion.
Get Expert Guidance – Connect with an Analyst: https://www.alliedmarketresearch.com/connect-to-analyst/A12693
Competitive Analysis
The AI in medical imaging market players profiled in the report include Siemens, NVIDIA Corporation, IBM Corporation, GE Healthcare, Koninklijke Philips N.V., Aidoc, Butterfly Network, Inc., Zebra Technologies Corp., Arterys Inc., and ICAD Inc. Various strategies such as collaborations & partnerships, product launches, and acquisitions have been adopted by market players to expand their foothold in the AI in medical imaging industry.
Key Findings of the Study
• Based on modality, the CT scan segment accounted-for major share of the market in 2022, while the X-rays segment is expected to witness faster growth during the forecast period.
• Based on technology, the deep learning segment accounted-for higher share of the market in 2022, while the computer vision segment is anticipated to increase faster during the forecast period.
• Based on application, the breast imaging segment dominated the market in 2022, while the orthopedics segment is expected to expand at a faster rate during the forecast period.
• Based on industry vertical, the hospital and healthcare providers segment dominated the market in 2022, while the patients segment is expected to expand at a faster rate during the forecast period.
• Based on region, North America accounted for the largest share of the global lighting control system market in 2022, while Asia-Pacific is anticipated to grow faster during the forecast period.
Contact us:
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Int’l: +1-503-894-6022
Toll Free: +1-800-792-5285
Fax: +1-800-792-5285
help@alliedmarketresearch.com
Web: http://www.alliedmarketresearch.com
Follow us on: https://www.linkedin.com/company/allied-market-research
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
